Send2Press Newswire
Sat, 29 Mar 2008 09:54:15 GMT
Epeius Biotechnologies Awarded U.S. Patent for Targeted Injectable Gene Delivery In Vivo
SAN MARINO, Calif., March 25 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation announced today the issue of U.S. Patent No. 7,347,998 for Targeted Gene Delivery in vivo. This patent provides additional intellectual property protection for the platform of highly advanced biotechnologies embodied in the company's leading anti-cancer agent, Rexin-G. Administered clinically by simple intravenous infusion, the Epeius tumor-targeted gene delivery system enables Rexin-G to seek out and accumulate selectively in cancerous tissues and remote metastatic tumor nodules that have spread throughout the body. Rexin-G delivers it tumor-killing payload precisely where it is needed most, by targeting cancer from the inside.
 Rexin-G demonstrates profound single agent efficacy in a broad spectrum of chemotherapy refractory cancers, including pancreatic cancer, breast cancer, colon cancer, squamous cell carcinoma of larynx, uterine cancer, gastric cancer, malignant melanoma, validating Epeius Biotechnologies' in vivo targeted gene delivery platform (Int'l J Oncol, 2006, 2007).
The response rates seen with Rexin-G are unmatched by any other tumor-targeted gene delivery system. The U.S. FDA has granted Orphan Drug Status to Rexin-G based on its performance as a single therapeutic agent in treating chemotherapy refractory pancreatic cancer. Based on its exemplary record of safety and efficacy as an anti-cancer agent in a broad spectrum of chemo-resistant tumors, Rexin-G received accelerated approval for the treatment of all solid tumors by the Philippine BFAD, leading to its registration.
Currently, Rexin-G is being tested as a single therapeutic agent in three separate U.S. Phase I/II Trials for recurrent or metastatic cancers of the breast or pancreas and for bone and soft tissue sarcoma respectively. Additionally, a Phase II Registration Protocol is underway for chemo-resistant osteosarcoma in Los Angeles, California.
About Epeius Biotechnologies
Epeius Biotechnologies Corporation is a privately held biopharmaceutical company dedicated to the advancement of genetic medicine with the development and commercialization of its proprietary targeted delivery systems.
Credited with innovations ranging from proto-oncogene discovery, designer therapeutics, pathotropic (disease-seeking) targeting, high-performance vector engineering, to advanced biopharmaceutical manufacturing and bioprocess development, Epeius Biotechnologies is well positioned to "launch" its enabling platform technologies for the benefit of cancer patients worldwide.
To learn more about Rexin-G(R) and the Epeius pipeline of proprietary biotechnologies currently available for licensing and clinical trials, please visit us at www.epeiusbiotech.com.
Copyright © 2008 Send2Press® Newswire, a unit of Neotrope®
TAGS: Send2Press Newswire, Epeius Biotechnologies RexinG, biopharmaceutical cancer research
Tue, 25 Mar 2008 01:05:29 GMT
IBC Announces Patent Pending on Energy Saving Technology
Insulated Electrical Box Expected to be Incorporated Into New Homes
BREVARD, N.C. - Feb. 19 (SEND2PRESS NEWSWIRE) -- Insulation Business Consultants announced today that the firm has developed a means of maintaining the thermal integrity of exterior walls, eliminating the voids in the insulation where electrical boxes (switch and receptacle boxes), create significant holes in the residential thermal envelope.
IBC invented the technology which incorporates insulating panels of Argon gas and an optional radiant barrier. IBC developed it while working on the development of a separate energy-saving technology relating to custom-formed batts for the Fibertek Corporation of Lakeland, Florida.
A University of North Dakota study in 2000 indicated that an average American home loses fifty dollars in heat energy each year through leakage of energy in and around electrical boxes. Since 2000, energy cost per unit, (BTU), has increased dramatically.
IBC found builders were unable to provide adequate insulation to the wall behind the electrical boxes using materials typically available on the jobsite. Thermal imaging always indicated substantial heat loss at the box regardless of efforts taken to mitigate the loss.
The new electrical box design allows building inspectors assurance that thermal performance of the exterior walls will comply with the existing building code language.
IBC is negotiating with several manufacturers of electrical boxes to incorporate the technology, and the newer boxes are expected to be available by summer of 2008.
Insulation Business Consultants (www.IBCofUSA.com) has long been involved with energy-saving technology. The firm owns insulation contracting companies and provides consultation services to insulation contracting services organizations nation-wide.
William Daviau
of: Insulation Business Consultants
Telephone: 828-883-4208
email - billdaviau @aol.com
176 Kituhwa Trail
Brevard, NC 28712
URL - http://www.ibcofusa.com/
Copyright © 2008 Send2Press® Newswire, a unit of Neotrope®
TAGS: Send2Press Newswire, Insulation Business Consultants, insulation contracting services
Tue, 19 Feb 2008 09:30:13 GMT
LogicEase Receives Notice of Allowance in the U.S. for Automated Loan Compliance Patent
SAN FRANCISCO, Calif. - Jan. 22 (SEND2PRESS NEWSWIRE) -- LogicEase Solutions Inc., provider of the mortgage industry's leading suite of risk management solutions - ComplianceEase(R), announced today it has received a Notice of Allowance for a patent on its automated compliance system from the United States Patent and Trademark Office. The allowed patent, "System and Method For Automated Compliance With Loan Legislation" primarily encompasses the ComplianceAnalyzer(R) automated compliance system.
 ComplianceAnalyzer examines mortgage loans and, in real-time, produces audit reports with summary and detailed findings regarding loan-level compliance with applicable laws and regulations at multiple jurisdictional levels. The awarding of the patent further validates ComplianceEase's innovation in the regulatory compliance space and recognizes it as the pioneer of this important technology.
"At ComplianceEase we have pioneered the field of automated lending compliance and I am very pleased that the United States Patent and Trademark Office has recognized the novel innovations that we have developed," said Jason Roth, senior vice president and named inventor on the patent. "This important milestone helps us give the residential mortgage industry confidence that we will continue to be the leading compliance automation provider for years to come."
In today's increasingly volatile market environment, regulatory compliance is becoming one of the most significant risk-management issues for financial institutions of all sizes. ComplianceEase's team of industry professionals recognized this need early on and created ComplianceAnalyzer - a web-based system that includes the use of rules-based artificial intelligence, an intuitive mapping of business concepts on the loan to concepts within the rules, and a natural language processor to manage all of the compliance rules in plain English sentences. The system not only determines if a loan complies with regulations but it also automatically determines which rules should apply to the loan, based on numerous aspects of the transaction in question.
About ComplianceEase
ComplianceEase, a division of LogicEase Solutions Inc., headquartered in the San Francisco Bay Area, is a premier provider of intelligent business solutions to the financial services industry. ComplianceEase's web-based platform, ComplianceAnalyzer, is the mortgage industry's leading automated compliance solution. The ComplianceEase expert system utilizes advanced reasoning and decisioning technologies as well as natural language processing to power beginning-to-end solutions in a fraction of the time and for a fraction of the cost of traditional approaches, while providing high levels of accuracy and integrity. ComplianceEase's significant and growing client base includes top tier mortgage lenders, banks, and Wall Street firms. The company is managed by a team of highly experienced and innovative mortgage professionals, and is funded by the First American Corporation, the WI Harper Group, and the senior management team.
For more information about ComplianceEase, please visit www.ComplianceEase.com.
Copyright © 2008 Send2Press® Newswire, a unit of Neotrope®
TAGS: Send2Press Newswire, ComplianceEase ComplianceAnalyzer software, Automated Compliance With Loan Legislation
Tue, 22 Jan 2008 00:00:01 GMT
Authernative Granted U.S. Patent on Key Conversion Method for Communication Session Encryption and Authentication System
REDWOOD CITY, Calif. - Nov. 26 (SEND2PRESS NEWSWIRE) -- Authernative, Inc., the developer of innovative user authentication and identity management technologies, announced today that the United States Patent & Trademark Office has granted the company its patent for a key conversion method.
 The newly issued patent number US 7,299,356 titled "Key conversion method for communication session encryption and authentication system" describes a new encryption key management system integrated into an interactive mutual authentication protocol that accomplishes mutual authentication through a secure exchange of session-only random symmetric encryption keys without allowing authentication credentials to cross non-trusted communication media.
Security of key distribution is enabled with a new Key Conversion Array (KCA(TM)) technology. It embraces sequential random number generators seeded with authentication credentials and arrays of veiling random bits and/or bytes. Furthermore, these veiling bits and/or bytes are replaced at certain session-only random positions in KCA with disassembled symmetric key's bits and/or bytes. Key scrambling process of replacing veiling bits and/or bytes inside KCA with the actual key's bits and/or bytes is reversed at the receiving end with a reciprocal key reengineering process according to one of patented Bit-Veil-Unveil (BitVU(TM)), Byte-Veil-Unveil (ByteVU(TM)), and Bit-Byte-Veil-Unveil (BBVU(TM)) algorithms.
The patented technology provides secure mutual authentication and session-only random symmetric key distribution in client-server architecture, which eliminates asymmetric key usage and overcomes certain weaknesses and difficulties in implementation, administration, maintenance, and cost containment of public key infrastructure (PKI), Kerberos, and some other commercially available authentication and key distribution systems and protocols. Key Conversion Array technology allows for security scalable with CPU power and network bandwidth, while KCA is highly resilient against communication session eavesdropping attacks, replay man-in-the-middle attacks, online and offline computer-processing attacks, and session hijacking/phishing attacks.
KCA(TM) technology extends the end-to-end security capabilities of Authernative(R) AuthGuard(R) user authentication solution. AuthGuard(R) performs strong user authentication and client-server mutual authentication during the authentication stage of the communication session. The secure session-only symmetric random encryption key distribution having occurred during this stage can protect secure content delivery between client and server during the post-authentication stage of the same communication session.
The rise and sophistication of online attacks, tools and strategies to steal authentication credentials and sensitive data are rapidly growing. According to the September 17, 2007, Internet Security Threat Report released by Symantec Corp, cyber criminals are increasingly becoming more professional - even commercial - in the development, distribution and use of malicious code and services. Authernative's Key Conversion Array technology gives end-users higher security and confidence when conducting Web-based transactions.
This patent issuance is a significant validation of the company's intellectual property and business strategy to protect user access and security of proprietary or sensitive data, which is essential to successfully conducting electronic business on a global basis. The company also currently holds more than 28 issued and pending US and foreign patents relating to the front- and back-end of authentication and encryption key management technologies.
Authernative has been expending the vision of AuthGuard(R) and the addition of the Key Conversion Array patented technology is a significant milestone, allowing for new product lines, including secure content delivery, single sign-on, and federated identity.
About Authernative:
Authernative provides innovative patented software security solutions offering identity and access management capabilities including authentication, authorization, administration, and auditing. The company's products are used to prevent unauthorized access to confidential data, protected resources, and financial transactions. They allow businesses to lower the cost of providing, deploying and managing user authentication for enabling e-commerce and addressing regulatory compliance requirements.
More information: www.authernative.com.
Copyright © 2007 Send2Press® Newswire, a unit of Neotrope®
TAGS: Send2Press Newswire, Authernative Inc, AuthGuard user authentication
Mon, 26 Nov 2007 09:36:41 GMT
The Original Patent Troll Returns
NORTH ATTLEBORO, Mass. - May 7 (SEND2PRESS NEWSWIRE) -- All of the fuss about Patent Trolls is driving coalitions of technology sector leaders to Washington, D.C. with their support of this year's Patent Reform Legislation. With all the fanfare, it is perfect timing for the Original Patent Troll to make his comeback in the recent re-release of "The Patents Video," from Intellectual Property Videos, LLC.
 In 1994, the Patent Troll made his first appearance in The Patents Video. At its first release, The Patents Video was purchased by hundreds of corporations, universities, governmental entities and law firms. In The Patents Video, an unsuspecting victim is surprised by the Original Patent Troll who strategically positioned himself to collect patent licensing revenue.
*(Photo Caption: The Original Patent Troll as seen in the re-released 1994 "The Patents Video")
Using dramatic vignettes, entertaining scenarios, humor and expert advice, The Patents Video explains the most commonly misunderstood concepts and the most critical information about patents. The Patents Video was designed to visually make key messages memorable. Topics include intellectual property (IP) law basics, domestic and foreign patent bar dates, patenting of ideas, and claim language with respect to patent infringement.
Engineers, scientists, marketers, managers, executives and corporate attorneys have a lesson in Bar Dates that no one forgets when they watch The Patents Video. Og, a caveman in a dream, has invented the wheel. Og and Thak push the wheel through downtown - all in public view. The Patents Video, an entertaining educational tool, explains how and why Og and Thak have lost their foreign patent filing rights and explains, in detail, how to avoid triggering U.S. and foreign patent Bar Dates.
A free viewing of a 3.5 minute clip from the 32 minute video is available by visiting www.ogandthak.com. YouTube viewers give the clip Five Stars.
Easy video streaming is available for $19.95 per view (volume discounts available) and a DVD copy can be purchased for $299 by visiting www.ogandthak.com. Continuing Legal Education (CLE) credit is also available.
Copyright © 2007 Send2Press® Newswire, a unit of Neotrope®
TAGS: Send2Press Newswire, Original Patent Troll, Intellectual Property Videos
Mon, 07 May 2007 15:00:00 GMT
|
